Understanding long-term neurodevelopmental outcomes of very and extremely preterm infants: A clinical review

Area of Science:

• Neonatal care
• Developmental pediatrics
• Neurology

Background:

• Infant survival rates for those born before 32 weeks gestation have improved.
• This improvement has led to a rise in neurodevelopmental morbidities among survivors.
• Very preterm infants are a vulnerable population requiring specialized long-term follow-up.

Purpose of the Study:

• To offer a clinical review of the long-term neurodevelopmental risks for very preterm infants.
• To inform healthcare providers about the ongoing challenges faced by this population.
• To emphasize the importance of vigilant monitoring and early intervention.

Main Methods:

• This article presents a clinical review based on existing literature.
• It synthesizes current knowledge on neurodevelopmental outcomes in very preterm infants.
• The review focuses on common morbidities and risk factors.

Main Results:

• Very preterm infants exhibit increased risks for cerebral palsy, cognitive delays, sensory impairments (deafness, blindness), and autism spectrum disorder compared to term-born infants.
• Severe neonatal complications such as Grade 3 or 4 intraventricular hemorrhage and necrotizing enterocolitis are associated with a higher risk of cerebral palsy.
• Maternal administration of magnesium sulfate for threatened preterm labor has been linked to a reduced risk of cerebral palsy in surviving neonates.

Conclusions:

• Most neurodevelopmental conditions in very preterm infants can be identified in early childhood with consistent follow-up care.
• General practitioners play a vital role in recognizing early signs of developmental problems in preterm survivors.
• Regular developmental surveillance is essential for identifying red flags and ensuring timely interventions for preterm infants.